<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Allgemein Archives - Dopavision</title>
	<atom:link href="https://dopavision.com/category/allgemein/feed/" rel="self" type="application/rss+xml" />
	<link>https://dopavision.com/category/allgemein/</link>
	<description></description>
	<lastBuildDate>Mon, 29 Jan 2024 09:23:12 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://dopavision.com/wp-content/uploads/2021/06/favicon-150x150.png</url>
	<title>Allgemein Archives - Dopavision</title>
	<link>https://dopavision.com/category/allgemein/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Printable Resources</title>
		<link>https://dopavision.com/2022/07/05/printable-resources/</link>
		
		<dc:creator><![CDATA[dopavision]]></dc:creator>
		<pubDate>Tue, 05 Jul 2022 13:08:33 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<guid isPermaLink="false">https://dopavision.com/?p=10453</guid>

					<description><![CDATA[<p>PRINTABLE RESOURCES Return to Portal Home Downloadable Resource Welcome letter Storyboard EN DOCPPT DE DOCPPT ES DOCPDF PT DOCPDF NL DOCPDF Daily schedule Activity cards Weekly schedule (1) Weekly schedule (2) Monthly schedule PDFPDFPDFPDFPDF PDFPDFPDFPDFPDF PDFPDFPDFPDFPDF PDFPDFPDFPDFPDF PDFPDFPDFPDFPDF Goal chart (1) Goal chart (2) PDFPDF PDFPDF PDFPDF PDFPDF PDFPDF At-home reward system Clinic reward system [&#8230;]</p>
<p>The post <a href="https://dopavision.com/2022/07/05/printable-resources/">Printable Resources</a> appeared first on <a href="https://dopavision.com">Dopavision</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>FAQs</title>
		<link>https://dopavision.com/2022/04/28/faqs/</link>
		
		<dc:creator><![CDATA[dopavision]]></dc:creator>
		<pubDate>Thu, 28 Apr 2022 11:15:48 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<guid isPermaLink="false">https://dopavision.com/?p=10320</guid>

					<description><![CDATA[<p>FREQUENTLY ASKED QUESTIONS Technical FAQs Trial FAQs Return to Portal Home Technical FAQs Download all FAQs as a PDF This section provides guidance on how to respond to some common technical concerns with which caregivers may reach out to you. If you do not feel confident helping a caregiver with a technical question, please assure [&#8230;]</p>
<p>The post <a href="https://dopavision.com/2022/04/28/faqs/">FAQs</a> appeared first on <a href="https://dopavision.com">Dopavision</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Report a Technical Issue</title>
		<link>https://dopavision.com/2022/04/21/report-a-technical-issue/</link>
		
		<dc:creator><![CDATA[dopavision]]></dc:creator>
		<pubDate>Thu, 21 Apr 2022 13:07:14 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<guid isPermaLink="false">https://dopavision.com/?p=10175</guid>

					<description><![CDATA[<p>REPORT A TECHNICAL ISSUE Technical Issue Form Return to Portal Home We encourage you to use this form to report technical issues you or participants may be experiencing. The information provided in this form goes directly to our Product team at Dopavision. One of our technical experts will review the report and get in touch [&#8230;]</p>
<p>The post <a href="https://dopavision.com/2022/04/21/report-a-technical-issue/">Report a Technical Issue</a> appeared first on <a href="https://dopavision.com">Dopavision</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Tips</title>
		<link>https://dopavision.com/2022/04/11/tips/</link>
		
		<dc:creator><![CDATA[dopavision]]></dc:creator>
		<pubDate>Mon, 11 Apr 2022 08:31:35 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<guid isPermaLink="false">https://dopavision.com/?p=10078</guid>

					<description><![CDATA[<p>Tips How to Navigate Technical Issues How to Report Technical Issues Return to Portal Home Navigating Technical Issues Download as a PDF Dopavision does its best to ensure that the MyopiaX and content apps have no technical issues. Yet, unforeseen technical issues may still occur during the MyopiaX-1 clinical trial. If a participant’s caregiver reports [&#8230;]</p>
<p>The post <a href="https://dopavision.com/2022/04/11/tips/">Tips</a> appeared first on <a href="https://dopavision.com">Dopavision</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Guides</title>
		<link>https://dopavision.com/2022/04/08/guides/</link>
		
		<dc:creator><![CDATA[dopavision]]></dc:creator>
		<pubDate>Fri, 08 Apr 2022 14:05:24 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<guid isPermaLink="false">https://dopavision.com/?p=9983</guid>

					<description><![CDATA[<p>GUIDES Weekly Low Adherence Calls Return to Portal Home Purpose: Understand why children have not been performing the recommended number of treatment sessions over the past week. Download as a PDF Goal: Motivate participating children and their caregivers to resume the twice daily treatment sessions as soon as possible by: Building rapport&#8230; inquire about how [&#8230;]</p>
<p>The post <a href="https://dopavision.com/2022/04/08/guides/">Guides</a> appeared first on <a href="https://dopavision.com">Dopavision</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Ensaio clínico</title>
		<link>https://dopavision.com/2022/01/05/clinical-trial-pt/</link>
		
		<dc:creator><![CDATA[dopavision]]></dc:creator>
		<pubDate>Wed, 05 Jan 2022 12:17:57 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<guid isPermaLink="false">https://dopavision.com/?p=9647</guid>

					<description><![CDATA[<p>ENSAIO CLÍNICO O QUE É O ENSAIO CLÍNICO MYOPIAX®? A finalidade deste ensaio é investigar os efeitos clínicos de MyopiaX® MyopiaX® é uma aplicação para smartphone que visa a abrandar a progressão (agravamento) da miopia em crianças e adolescentes. Estamos a levar a cabo um ensaio clínico (NCT04967287) para estudar a segurança e o efeito do [&#8230;]</p>
<p>The post <a href="https://dopavision.com/2022/01/05/clinical-trial-pt/">Ensaio clínico</a> appeared first on <a href="https://dopavision.com">Dopavision</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Klinisch onderzoek</title>
		<link>https://dopavision.com/2022/01/05/clinical-trial-nl/</link>
		
		<dc:creator><![CDATA[dopavision]]></dc:creator>
		<pubDate>Wed, 05 Jan 2022 11:31:02 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<guid isPermaLink="false">https://dopavision.com/?p=9567</guid>

					<description><![CDATA[<p>MEDISCH WETENSCHAPPELIJK ONDERZOEK WAT HOUDT HET MEDISCH WETENSCHAPPELIJKE MYOPIAX®-ONDERZOEK IN? Het doel is het onderzoeken van de effecten van MyopiaX® MyopiaX® is een smartphone-applicatie, dat het verslechteren van bijziendheid bij kinderen en adolescenten wil vertragen. We voeren een medisch wetenschappelijk onderzoek uit (NCT04967287) om de veiligheid en werkzaamheid van MyopiaX® bij het verslechteren van bijziendheid te [&#8230;]</p>
<p>The post <a href="https://dopavision.com/2022/01/05/clinical-trial-nl/">Klinisch onderzoek</a> appeared first on <a href="https://dopavision.com">Dopavision</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Klinische Studie</title>
		<link>https://dopavision.com/2022/01/05/clinical-trial-de/</link>
		
		<dc:creator><![CDATA[dopavision]]></dc:creator>
		<pubDate>Wed, 05 Jan 2022 11:07:54 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<guid isPermaLink="false">https://dopavision.com/?p=9500</guid>

					<description><![CDATA[<p>KLINISCHE STUDIE WORUM GEHT ES BEI DER KLINISCHEN MYOPIAX®-STUDIE? In dieser Studie soll die klinische Wirkung von MyopiaX® untersucht werden. MyopiaX® ist eine Smartphone-Anwendung, die auf die Verlangsamung des Fortschreitens (Verschlechterung) der Myopie, oder Kurzsichtigkeit, bei Kindern und Jugendlichen abzielt. Wir führen eine klinische Studie (NCT04967287) durch, um die Sicherheit und Wirkung der MyopiaX® Behandlung [&#8230;]</p>
<p>The post <a href="https://dopavision.com/2022/01/05/clinical-trial-de/">Klinische Studie</a> appeared first on <a href="https://dopavision.com">Dopavision</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Ensayo clínico</title>
		<link>https://dopavision.com/2022/01/05/clinical-trial-es/</link>
		
		<dc:creator><![CDATA[dopavision]]></dc:creator>
		<pubDate>Wed, 05 Jan 2022 10:53:10 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<guid isPermaLink="false">https://dopavision.com/?p=9417</guid>

					<description><![CDATA[<p>ENSAYO CLÍNICO ¿QUÉ ES ELENSAYO CLÍNICO MYOPIAX®? El objetivo de este ensayo es investigar los efectos clínicos de MyopiaX® MyopiaX® es una aplicación para smartphone cuyo objetivo es ralentizar la progresión de la miopía en niños y adolescentes. Estamos llevando a cabo un ensayo clínico (NCT04967287) para investigar la seguridad y el efecto del tratamiento con [&#8230;]</p>
<p>The post <a href="https://dopavision.com/2022/01/05/clinical-trial-es/">Ensayo clínico</a> appeared first on <a href="https://dopavision.com">Dopavision</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
